Related Experiment Video

Updated: Aug 25, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

Importance of correlative science in advancing hormonal therapy and a new clinical paradigm for neoadjuvant therapy

Matthew J Ellis1

  • 1Washington University School of Medicine, Section of Medical Oncology and Breast Cancer Program, St. Louis, Missouri, USA. mellis@im.wustl.edu

Annals of Surgical Oncology
|March 16, 2004
PubMed

Insights

Understanding endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer is key. Neoadjuvant treatment reveals distinct outcomes with tamoxifen versus letrozole, especially in HER1/HER2 co-expressing tumors.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Endocrine therapy resistance is a major challenge in treating estrogen receptor (ER)-positive breast cancer.
  • Neoadjuvant endocrine therapy allows for comparative analysis of tumor biopsies before and after treatment.

Purpose of the Study:

  • To investigate molecular mechanisms underlying resistance to endocrine therapy in ER-positive breast cancer.
  • To compare the effects of tamoxifen and letrozole on molecular markers in a neoadjuvant setting.

Main Methods:

  • Utilizing a randomized trial of neoadjuvant tamoxifen versus letrozole.
  • Performing semiquantitative analysis of molecular marker expression in pre-treatment and post-treatment tumor biopsies.
  • Focusing on growth factor pathways, including HER1 (epidermal growth factor receptor [EGFR]) and HER2, that interact with the ER.

Main Results:

  • Distinct mechanisms of ER signaling inhibition by tamoxifen and letrozole were observed.
  • Significant differences in clinical and biomarker outcomes were noted in tumors co-expressing ER with HER1 and/or HER2.
  • Estrogen deprivation therapy showed a favorable trend in this specific subset of tumors.

Conclusions:

  • The choice of endocrine therapy (tamoxifen vs. letrozole) can impact outcomes differently, particularly in tumors with co-expressed growth factor receptors.
  • Further research into gene expression profiles and growth factor signaling inhibitors is warranted to overcome tamoxifen resistance.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hormonal Regulation01:40

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.